Full Text
Assessment of Commercial and Market Access Potential and Considerations for an Ultra-Orphan Drug for Renal Disease in EU5

Abstract

Authors

LA Smith A Edathodu JJ Samuel SR Mukku

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×